TotalMarketCap

Kazia Therapeutics

KZIANasdaq AustraliaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$109.697 M

$7.06 -12.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Kazia Therapeutics (KZIA) has a market capitalization of $109.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #282Foghorn TherapeuticsFHTX$113.1M
  2. #283Minerva NeurosciencesNERV$109.8M
  3. #284Kazia TherapeuticsKZIA$109.7M
  4. #285OrganogenesisORGO$107.9M
  5. #286Anixa BiosciencesANIX$105.0M

What if Kazia Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,816,007

Per share 257,407× higher

Bitcoin $1.53T

$98,260.99

Per share 13,928× higher

Apple $5.02T

$322,581.64

Per share 45,724× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Kazia Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.